CairnSurgical, Inc.
PrivateLast Round
Series A2
Aug 21, 2024
Est. Valuation
$59.5M
Total Funding Raised
$12.64M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CairnSurgical, Inc. operates in Healthcare & Life Sciences and is based in Lebanon, New Hampshire. Its latest recorded funding round was a Series A2 round in August 2024.
CairnSurgical, Inc. is a medical device company that develops patient-specific surgical guides using patient imaging data and 3D printing technologies to improve the precision of breast cancer surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, 3D Printing, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CairnSurgical, Inc. Comparables
Compare CairnSurgical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sirius Medical | 83% | |
| Stryker Corporation | 78% | |
| OncoRes Medical | 76% |
For institutional investors. Book with your work email.
CairnSurgical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A2 | Aug 21, 2024 | ||||
| Grant | Aug 25, 2020 | ||||
| Series A | Dec 4, 2019 | ||||
| Grant | Sep 1, 2019 | ||||
| Accelerator | Jan 29, 2019 | ||||
Grant | Sep 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CairnSurgical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Series A, Grant |
| Morningside Ventures | Series A, Series A2 |
| DRIVEN Accelerator Hub | Series A, Accelerator |
| Morningside Group | Series A |
| New Hampshire Innovation Research Center | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 56% MoM.
- Jun 18, 2026
Monthly visitors increased 32% MoM.
For institutional investors. Book with your work email.
CairnSurgical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CairnSurgical, Inc.'s valuation, stock price, and market status.
Is CairnSurgical, Inc. a public or private company?
CairnSurgical, Inc. is a private company.
What is the current stock price of CairnSurgical, Inc.?
CairnSurgical, Inc. is a private company, so its shares have no public market price. Caplight tracks CairnSurgical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CairnSurgical, Inc. worth (valuation)?
CairnSurgical, Inc.'s valuation is estimated at $59.5M based on funding round data.
Can I buy CairnSurgical, Inc. stock?
CairnSurgical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CairnSurgical, Inc.'s last funding round?
CairnSurgical, Inc.'s most recent funding round was Series A2 on August 21, 2024.
Who are the main investors in CairnSurgical, Inc.?
Key investors in CairnSurgical, Inc. include Morningside Ventures, Morningside Group.
Will CairnSurgical, Inc. IPO soon?
No public IPO plans have been announced for CairnSurgical, Inc..
How can I track CairnSurgical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in CairnSurgical, Inc.'s shares on secondary markets.